The Enterprise Value as of January 2025 (TTM) for Provention Bio, Inc. (PRVB) is 2.36B

According to Provention Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.36B. This represents a change of 468.79% compared to the average of 414.09M of the last 4 quarters.

Provention Bio, Inc. (PRVB) Historical Enterprise Value (quarterly & annually)

How has PRVB Enterprise Value performed in the past?

The mean historical Enterprise Value of Provention Bio, Inc. over the last ten years is 360.58M. The current 2.36B Enterprise Value has changed 65.22% with respect to the historical average. Over the past ten years (40 quarters), PRVB's Enterprise Value was at its highest in in the December 2020 quarter at 855.56M. The Enterprise Value was at its lowest in in the December 2018 quarter at -18818430.00.

Provention Bio, Inc. (PRVB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Provention Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Provention Bio, Inc. (PRVB) Average Enterprise Value

How has PRVB Enterprise Value performed in the past?

The current Enterprise Value of Provention Bio, Inc. (PRVB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Provention Bio, Inc. (PRVB) Enterprise Value vs. Peers

How is PRVB’s Enterprise Value compared to its peers?

Provention Bio, Inc.’s Enterprise Value is less than IVERIC bio, Inc. (5.13B), less than Immunovant, Inc. (3.28B), greater than Akero Therapeutics, Inc. (1.69B), less than Madrigal Pharmaceuticals, Inc. (6.85B), less than Apellis Pharmaceuticals, Inc. (4.13B), less than Prometheus Biosciences, Inc. (0), less than Viking Therapeutics, Inc. (9.30B), less than Intercept Pharmaceuticals, Inc. (4.62B), greater than Terns Pharmaceuticals, Inc. (915.81M), greater than Reata Pharmaceuticals, Inc. (217.02M), less than BioLineRx Ltd. (6.64B), greater than Ardelyx, Inc. (44.21M), greater than Lexicon Pharmaceuticals, Inc. (1.30B), greater than Seres Therapeutics, Inc. (351.86M), greater than ImmunityBio, Inc. (170.14M), less than null (2.55B),

Build a custom stock screener for Provention Bio, Inc. (PRVB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Provention Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Provention Bio, Inc. (PRVB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Provention Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.